JASON KEITER: Open Payments
NPI 1578992855 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$476 in 12 payments from 8 companies in 2025. Trend: 2023 $2,063 · 2024 $238 · 2025 $476
Food & beverage: $476
| Company | Payments | Amount |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 1 | $171 |
| Sumitomo Pharma America, Inc. | 3 | $98 |
| Daiichi Sankyo Inc. | 3 | $88 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Blue Earth Diagnostics | 1 | $24 |
| Procept Biorobotics Corporation | 1 | $23 |
| COLOPLAST CORP | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: ADSTILADRIN, GEMTESA, Enhertu, DATROWAY, POSLUMA, AQUABEAM ROBOTIC SYSTEM, SenSura Mio, WELIREG.
Industry payments across FL — which companies pay providers there.
